CRC Round 25

Application details Application summary

Additive Manufacturing CRC

Grant funding (GST excl):
$57,500,000 over 7 years

Partner Contributions:
$209,755,269 (cash and in-kind)

Additive Manufacturing (AM), or 3D printing, revolutionises the production of complex, high-value customised products, offering vast potential, impact, and opportunity for Australian industry. Bringing together our significant AM research community and ambitious companies, the Additive Manufacturing CRC will establish a world-class AM ecosystem spanning the entire value chain. As a result, industry will be able to accelerate innovation, explore new business models, harness new sustainable materials and certify production. This will support the widespread industrial adoption of AM technologies, contributing significantly to enhanced productivity, resource conservation, and future resilience, whilst bolstering a skilled and expanded workforce.

Care Economy CRC

Grant funding (GST excl):
$35,000,000 over 10 years

Partner Contributions:
$92,332,297 (cash and in-kind)

Australia’s $327B care economy is a critical industry sector facing compounding challenges driven by increased demand for care services and a shortfall in skilled care workers. The Care Economy CRC brings together researchers, technologists, and care service providers from diverse sectors to co-develop, customise, implement, and commercialise new technologies, data solutions, and models of care to improve competitiveness, productivity and sustainability of Australian Care industries. The CRC will address workforce retention and flexibility issues and the digital skills gaps that act as a barrier to technology adoption. The CRC's cohort of industry-ready higher degree research students will promote and sustain innovation in the care economy.

SMART CRC

Grant funding (GST excl):
$65,000,000 over 10 years

Partner Contributions:
$173,182,189 (cash and in-kind)

Australia has a shortage of manufacturing capability for life-changing regenerative therapies. The SMART CRC (Solutions for Manufacturing Advanced Regenerative Therapies CRC) will address the urgent need to manufacture cures for disease and disability that burdens Australia’s rapidly aging population. This will accelerate job creation and train the necessary workforce to support the growth and sustained development of our regenerative therapy sector. By galvanising and growing Australia’s capacity to manufacture a pipeline of curative treatments for cancer, heart diseases, arthritis and other age-related ailments, the CRC will reduce pressure on our hospital networks and keep Australians healthier for longer.